Comparing the incidence of ventricular arrhythmias during epicardial ablation in swine versus canine models.

animal model electrophysiology cardiovascular devices preclinical cardiology radiofrequency catheter ablation ventricular arrhythmia

Journal

Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Titre abrégé: Pacing Clin Electrophysiol
Pays: United States
ID NLM: 7803944

Informations de publication

Date de publication:
07 2019
Historique:
received: 04 10 2018
revised: 14 03 2019
accepted: 11 04 2019
pubmed: 17 4 2019
medline: 2 7 2020
entrez: 17 4 2019
Statut: ppublish

Résumé

Choosing the appropriate animal model for development of novel technologies requires an understanding of anatomy and physiology of these different models. There are little data about the characteristics of different animal models for the study of technologies used for epicardial ablation. We aimed to compare the incidence of ventricular arrhythmias during epicardial radiofrequency ablation between swine and canine models using novel epicardial ablation catheters. We conducted a retrospective study using data obtained from epicardial ablation experiments performed on swine (Sus Scrofa) and canine (Canis familiaris) models. We compared the incidence of ventricular arrhythmias during ablation between swine and canine using multivariate regression analysis. Six swine and six canine animals underwent successful epicardial radiofrequency ablation. A total of 103 ablation applications were recorded. Ventricular arrhythmias requiring cardioversion occurred in 13.11% of radiofrequency ablation applications in swine and 9.75% in canine (relative risk: 117.6%, 95% confidence interval [CI]: 83.97-164.69, animal-based odds ratio [OR]: .55, 95% CI: .23-61.33; P = .184). When adjusting for application position, duration of ablation and power, the odds of developing potentially lethal ventricular arrhythmia in swine increased significantly compared to canine (OR: 3.60, 95% CI: 1.35-9.55; P = .010). The swine myocardium is more susceptible to developing ventricular arrhythmias compared to canine model during epicardial ablation. This issue should be carefully considered in future studies.

Sections du résumé

BACKGROUND
Choosing the appropriate animal model for development of novel technologies requires an understanding of anatomy and physiology of these different models. There are little data about the characteristics of different animal models for the study of technologies used for epicardial ablation. We aimed to compare the incidence of ventricular arrhythmias during epicardial radiofrequency ablation between swine and canine models using novel epicardial ablation catheters.
METHODS
We conducted a retrospective study using data obtained from epicardial ablation experiments performed on swine (Sus Scrofa) and canine (Canis familiaris) models. We compared the incidence of ventricular arrhythmias during ablation between swine and canine using multivariate regression analysis. Six swine and six canine animals underwent successful epicardial radiofrequency ablation. A total of 103 ablation applications were recorded.
RESULTS
Ventricular arrhythmias requiring cardioversion occurred in 13.11% of radiofrequency ablation applications in swine and 9.75% in canine (relative risk: 117.6%, 95% confidence interval [CI]: 83.97-164.69, animal-based odds ratio [OR]: .55, 95% CI: .23-61.33; P = .184). When adjusting for application position, duration of ablation and power, the odds of developing potentially lethal ventricular arrhythmia in swine increased significantly compared to canine (OR: 3.60, 95% CI: 1.35-9.55; P = .010).
CONCLUSIONS
The swine myocardium is more susceptible to developing ventricular arrhythmias compared to canine model during epicardial ablation. This issue should be carefully considered in future studies.

Identifiants

pubmed: 30989679
doi: 10.1111/pace.13698
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

862-867

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Guido Caluori (G)

International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
CEITEC, Masaryk University, Brno, Czech Republic.

Adam Wojtaszczyk (A)

International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
3rd Department of Cardiology, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia, Katowice, Poland.

Omar Yasin (O)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Martin Pesl (M)

International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
First Department of Internal Medicine/Cardioangiology, St. Anne´s Hospital, Masaryk University, Brno, Czech Republic.
Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Jiří Wolf (J)

International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.

Silvie Belaskova (S)

International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.

Michal Crha (M)

University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic.

Alan Sugrue (A)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Vaibhav R Vaidya (VR)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Niyada Naksuk (N)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Christopher V DeSimone (CV)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Ammar M Killu (AM)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Deepak Padmanabhan (D)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Samuel J Asirvatham (SJ)

Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.
Department of Pediatrics and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota.

Zdeněk Stárek (Z)

International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
First Department of Internal Medicine/Cardioangiology, St. Anne´s Hospital, Masaryk University, Brno, Czech Republic.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

Classifications MeSH